Literature DB >> 16173785

Affinity enhancement bivalent morpholinos for pretargeting: surface plasmon resonance studies of molecular dimensions.

Jiang He1, Xinrong Liu, Surong Zhang, Guozheng Liu, Donald J Hnatowich.   

Abstract

Bivalent effectors have been reported to provide superior pretargeting by affinity enhancement. We recently reported that one bivalent MORF (phosphorodiamidate morpholino, a DNA analogue oligomer) exhibited affinity enhancement (ratio of bivalent to monovalent equilibrium constants for binding) to immobilized complementary DNA (cDNA) by surface plasmon resonance (SPR). Because bivalent effectors using oligomers are easily synthesized with molecular spacing between binding sites, an important determinant of binding, adjustable simply by selecting linkers of different dimensions and/or lengthening or shortening the oligomer chain length, they may have advantages over existing bivalent effectors. We synthesized four bivalent MORFs with different dimensions between binding sites and measured binding affinities and affinity enhancement by SPR. An 18 mer (MORF18) was made bivalent by dimerizing both with disuccinimidyl suberate (DSS) and disuccinimidyl glutarate (DSG) linkers. By again using DSS but adding seven nonbinding adenine bases and by eliminating six binding bases, a total of four bivalent effectors, DSS-MORF12, DSG-MORF18, DSS-MORF18, and DSS-MORF25, were prepared with two different hybridization affinities (i.e. MORF12 and MORF18/25) and three different spacings (i.e. 20, 25, and 100 angstroms) between binding sites. The biotinylated cDNA was immobilized on a sensor chip at 500 and 100 RU coating densities providing an average cDNA separation of 25 and 80 angstroms. As expected, bimolecular binding dominated monomolecular binding in all cases, especially at lower MORF effector concentrations and at higher coating densities. All bivalent MORFs showed equilibrium constants superior to their monovalent form and therefore affinity enhancement. DSS-MORF25 showed the highest equilibrium constant for bimolecular binding presumably because of its larger separation between binding sites. Nevertheless, DSS-MORF12 showed the largest affinity enhancement of almost 3 orders of magnitude presumably because the shorter chain lowered the equilibrium constant for monomolecular binding. We have shown that bivalent effectors may be easily synthesized using MORF. The results provide further evidence that the use of bivalent effectors can greatly improve MORF pretargeting and, finally, that bivalent MORFs with reduced equilibrium constants may actually exhibit higher affinity enhancement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16173785     DOI: 10.1021/bc050061s

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  9 in total

1.  Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF.

Authors:  Jiang He; Yi Wang; Shuping Dou; Xinrong Liu; Surong Zhang; Guozheng Liu; Donald Hnatowich
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

2.  Comparison of several linear fluorophore- and quencher-conjugated oligomer duplexes for stability, fluorescence quenching, and kinetics in vitro and in vivo in mice.

Authors:  Surong Zhang; Guozheng Liu; Xinrong Liu; Dongguang Yin; Shuping Dou; Jiang He; Mary Rusckowski; Donald J Hnatowich
Journal:  Bioconjug Chem       Date:  2007-05-19       Impact factor: 4.774

3.  Optical pretargeting of tumor with fluorescent MORF oligomers.

Authors:  Jiang He; Mary Rusckowski; Yi Wang; Shuping Dou; Xinrong Liu; Surong Zhang; Guozheng Liu; Donald J Hnatowich
Journal:  Mol Imaging Biol       Date:  2007 Jan-Feb       Impact factor: 3.488

4.  Successful radiotherapy of tumor in pretargeted mice by 188Re-radiolabeled phosphorodiamidate morpholino oligomer, a synthetic DNA analogue.

Authors:  Guozheng Liu; Shuping Dou; George Mardirossian; Jiang He; Surong Zhang; Xinrong Liu; Mary Rusckowski; Donald J Hnatowich
Journal:  Clin Cancer Res       Date:  2006-08-15       Impact factor: 12.531

5.  Novel DNA Polymer for Amplification Pretargeting.

Authors:  Xiao Li; Qingqing Huang; Jie Xiao; Guozheng Liu; Shuping Dou; Mary Rusckowski; Hongcheng Shi; Yuxia Liu; Dengfeng Cheng
Journal:  ACS Med Chem Lett       Date:  2015-07-27       Impact factor: 4.345

6.  An improved method for covalently conjugating morpholino oligomers to antitumor antibodies.

Authors:  Jiang He; Guozheng Liu; Shuping Dou; Suresh Gupta; Mary Rusckowski; Donald Hnatowich
Journal:  Bioconjug Chem       Date:  2007-03-27       Impact factor: 4.774

7.  Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis.

Authors:  Christopher S Chandler; Meghan M Bell; Sebastian K Chung; Darren R Veach; Edward K Fung; Blesida Punzalan; Daniela Burnes Vargas; Mitesh Patel; Hong Xu; Hong-Fen Guo; Brian H Santich; Pat B Zanzonico; Sébastien Monette; Garrett M Nash; Andrea Cercek; Achim Jungbluth; Neeta Pandit-Taskar; Nai Kong V Cheung; Steven M Larson; Sarah M Cheal
Journal:  Mol Cancer Ther       Date:  2021-10-19       Impact factor: 6.009

Review 8.  A semiempirical model of tumor pretargeting.

Authors:  Guozheng Liu; Donald J Hnatowich
Journal:  Bioconjug Chem       Date:  2008-11-19       Impact factor: 4.774

9.  Pretargeted molecular imaging and radioimmunotherapy.

Authors:  David M Goldenberg; Chien-Hsing Chang; Edmund A Rossi; William J; Robert M Sharkey
Journal:  Theranostics       Date:  2012-05-17       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.